Alteration in Mean Platelet Volume and Platicrit Values in Patients With Cancer That Developed Thrombosis

被引：47

作者：

Mutlu, Hasan ^{[1
]}

Artis, Tarik A. ^{[2
]}

Erden, Abduelsamet ^{[3
]}

Akca, Zeki ^{[4
]}

机构：

[1] Kayseri Training & Res Hosp, Dept Med Oncol, Kayseri, Turkey

[2] Erciyes Univ, Dept Gen Surg, Fac Med, Kayseri, Turkey

[3] Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey

[4] Mersin Govt Hosp, Dept Radiat Oncol, Mersin, Turkey

来源：

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2013年 / 19卷 / 03期

关键词：

deep venous thrombosis; thrombosis; thrombosis prophylaxis; ARTERIAL THROMBOEMBOLIC EVENTS; RISK; ANGIOGENESIS; MORTALITY; DISEASE; SIZE;

D O I：

10.1177/1076029611433644

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Mean platelet volume (MPV) is an indicator of thrombocyte volume and tendency to thrombosis can be mentioned in case of MPV elevation. Cancers are one of the important groups of thrombotic diseases. In the present study, MPV value was scrutinized in patients with cancer that developed thrombosis. Totally 43 patients followed in Kayseri Training and Research Hospital, in who thromboembolus has been developed, were prospectively recruited in the study. Thrombocyte, MPV, and platicrit (PCT) values were recorded at the time of cancer diagnosis and thrombosis development. Frequency analysis, crosstabs, and paired samples t test were used. Analyses showed that MPV values at the time of thrombosis development were significantly low as compared to those at the time of cancer diagnosis (P = .041). Thrombocyte count and PCT values were also low but not significant. The result of the present study is likely to show that thrombocytes have ignorable effect on thrombosis development in patients with cancer.

引用

页码：331 / 333

页数：3

共 21 条

[1] Thromboembolism in cancer patients: Pathogenesis and treatment
Adess, Matthew
Eisner, Robert
Nand, Sucha
Godwin, John
Messmore, Harry L., Jr.
Wehrmacher, William H.
[J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (03) : 254 - 266
[2] Platelet size: Measurement, physiology and vascular disease
Bath, PMW
Butterworth, RJ
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) : 157 - 161
[3] Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, JW
Doggen, CJM
Osanto, S
Rosendaal, FR
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06): : 715 - 722
[4] Chew HK, 2006, ARCH INTERN MED, V166, P458
[5] Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease
Endler, G
Klimesch, A
Sunder-Plassmann, H
Schillinger, M
Exner, M
Mannhalter, C
Jordanova, N
Christ, G
Thalhammer, R
Huber, K
Sunder-Plassmann, R
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (02) : 399 - 404
[6] Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism
Goldenberg, N
Kahn, SR
Solymoss, S
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4194 - 4199
[7] Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events?
Greisenegger, S
Endler, G
Hsieh, K
Tentschert, S
Mannhalter, C
Lalouschek, W
[J]. STROKE, 2004, 35 (07) : 1688 - 1691
[8] Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
Heit, JA
Silverstein, MD
Mohr, DN
Petterson, TM
O'Fallon, WM
Melton, LJ
[J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) : 809 - 815
[9] Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer
Khorana, Alok A.
Francis, Charles W.
Blumberg, Neil
Culakova, Eva
Refaai, Majed A.
Lyman, Gary H.
[J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (21) : 2377 - 2381
[10] Lee AYY, 2008, CANC PRINCIPLES PRAC, P2634

← 1 2 3 →